Effect of Intracameral Air Injection on Corneal Endothelial Cell Loss After Phacoemulsification for Cataracts of LOCS III Nuclear Grade 4 or Higher: A Randomised Clinical Trial
- Journal
- Clinical & experimental ophthalmology (Q1)
- Published
- 14 September 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Rui Feng, Ruijue Peng, Shiyan Chen, Binjian Wang, Anqi Li, Yanni Luo, et al.
- PMID
- 42734093
- DOI
- 10.1111/ceo.70161
Why clinicians should know about it
- Picked for Ophthalmology (top studies of the week, 20 September 2026): Intracameral air reduces endothelial cell loss after phacoemulsification
Abstract
BACKGROUND: To evaluate the effect of intracameral air injection on corneal endothelial cells in patients undergoing phacoemulsification for cataracts with LOCS III nuclear grade 4 or higher. METHODS: A prospective randomised clinical trial. Patients with cataracts of LOCS III nuclear grade 4 or higher were recruited from Sichuan Provincial People's Hospital between October 2024 and March 2025. Patients were randomised 1:1 to the intracameral air injection group (study group) or the conventional group (control group). Corneal endothelial parameters were assessed at 1 week and 1 month postoperatively. RESULTS: Eighty eyes from 80 patients (mean [SD] age, 68.9 [8.4] years; 43 females [53.8%]) were randomised to the study group (40 [50.0%]) or the control group (40 [50.0%]), with 34 eyes (85.0%) and 35 eyes (87.5%) completing the 1-month follow-up. Postoperative endothelial cell loss (ECL) in the study group was significantly lower than in the control group at 1 week (mean [SD], 6.90% [3.23%] vs. 12.81% [6.32%]; difference, -5.90%; 95% CI, -8.15% to -3.66%; p < 0.001) and at 1 month (mean [SD], 8.15% [3.84%] vs. 15.97% [6.11%]; difference, -7.82%; 95% CI, -10.10% to -5.55%; p < 0.001). For the secondary outcome, the study group showed a smaller increase in central corneal thickness (CCT) than the control group at 1 week (p = 0.02). CONCLUSIONS: Intracameral air injection was associated with lower ECL after phacoemulsification in cataracts with LOCS III nuclear grade 4 or higher. The smaller increase in CCT also suggested a potential benefit for early postoperative corneal recovery. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT06636279.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.